Bacteriophages to control Shiga toxin-producing E. coli – safety and regulatory challenges

References

• Conway T, Cohen PS. Commensal and pathogenic Escherichia coli metabolism in the gut. Microbiol Spectr. 2015;3:343–362.
   Web of Science ®Google Scholar
• Chaudhuri RR, Henderson IR. The evolution of the Escherichia coli phylogeny. Infect Genet Evol. 2012;12(2):214–226.
   PubMed Web of Science ®Google Scholar
• Clements A, Young JC, Constantinou N, et al. Infection strategies of enteric pathogenic Escherichia coli. Gut Microbes. 2012;3(2):71–87.
   PubMed Web of Science ®Google Scholar
• Tenaillon O, Skurnik D, Picard B, et al. The population genetics of commensal Escherichia coli. Nat Rev Microbiol. 2010;8(3):207–217.
   PubMed Web of Science ®Google Scholar
• Almeida C, Sousa JM, Rocha R, et al. Detection of Escherichia coli O157 by peptide nucleic acid fluorescence in situ hybridization (PNA-FISH) and comparison to a standard culture method. Appl Environ Microbiol. 2013;79(20):6293–6300.
   PubMed Web of Science ®Google Scholar
• Robinson AL, Mckillip JL. Biology of Escherichia coli O157:H7 in human health and food safety with emphasis on sublethal injury and detection. Curr Res Technol Educ Top Appl Microbiol Microb Biotechnol. 2010;2:1096–1105.
   Google Scholar
• Asea A, Kaur P, Chakraborti A. Enteroaggregative Escherichia coli: an emerging enteric food borne pathogen. Interdiscip Perspect Infect Dis. 2010;2010:254159.
   PubMedGoogle Scholar
• Croxen MA, Law RJ, Scholz R, et al. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev. 2013;26(4):822–880.
   PubMed Web of Science ®Google Scholar
• Robins-Browne RM, Holt KE, Ingle DJ, et al. Are Escherichia coli pathotypes still relevant in the era of whole-genome sequencing? Front Cell Infect Microbiol. 2016;6:141–149.
   PubMed Web of Science ®Google Scholar
• Werber D, Krause G, Frank C, et al. Outbreaks of virulent diarrheagenic Escherichia coli - are we in control? BMC Med. 2012;10(1):11.
   PubMedGoogle Scholar
• Ranjbar R, Masoudimanesh M, Dehkordi FS, et al. Shiga (Vero)-toxin producing Escherichia coli isolated from the hospital foods virulence factors, o-serogroups and antimicrobial resistance properties. Antimicrob Resist Infect Control. 2017;6:1–11.
   Web of Science ®Google Scholar
• Kerangart S, Douëllou T, Delannoy S, et al. Variable tellurite resistance profiles of clinically-relevant Shiga toxin-producing Escherichia coli (STEC) influence their recovery from foodstuffs. Food Microbiol. 2016;59:32–42.
   PubMed Web of Science ®Google Scholar
• Newell DG, La Ragione RM. Enterohaemorrhagic and other Shiga toxin-producing Escherichia coli (STEC): where are we now regarding diagnostics and control strategies? Transbound Emerg Dis. 2018;65(1):49–71.
   PubMedGoogle Scholar
• European Food Safety Authority, European Centre for Disease Prevention and Control (ECDC). The European Union summary report on trends and sources of zoonoses, zoonotic agents and food‐borne outbreaks in 2015. EFSA J. 2015;13(12):4329.
   Web of Science ®Google Scholar
• Karmali MA, Gannon V, Sargeant JM. Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol. 2010;140(3–4):360–370.
   PubMed Web of Science ®Google Scholar
• Steyert SR, Sahl JW, Fraser CM, et al. Comparative genomics and stx phage characterization of LEE-negative Shiga toxin-producing Escherichia coli. Cell Infect Microbiol. 2012;2:1–18.
   PubMed Web of Science ®Google Scholar
• Krüger A, Lucchesi PMA. Shiga toxins and stx phages: highly diverse entities. Microbiology. 2015;161(3):451–462.
   PubMedGoogle Scholar
• Ercoli L, Farneti S, Zicavo A, et al. Prevalence and characteristics of verotoxigenic Escherichia coli strains isolated from pigs and pork products in Umbria and Marche regions of Italy. Int J Food Microbiol. 2016;232:7–14.
   PubMed Web of Science ®Google Scholar
• Jacewicz M, Clausen H, Nudelman E, et al. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med. 1986;163(6):1391–1404.
   PubMed Web of Science ®Google Scholar
• Lee M-S, Tesh V. Roles of Shiga toxins in immunopathology. Toxins. 2019;11:212.
   PubMed Web of Science ®Google Scholar
• Robinson CM, Sinclair JF, Smith MJ, et al. Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization. Proc Natl Acad Sci USA. 2006;103(25):9667–9672.
   PubMed Web of Science ®Google Scholar
• Allué-Guardia A, Martínez-Castillo A, Muniesa M. Persistence of infectious shiga toxin-encoding bacteriophages after disinfection treatments. Appl Environ Microbiol. 2014;80(7):2142–2149.
   PubMed Web of Science ®Google Scholar
• Martí-Nez-Castillo A, Muniesa M. Implications of free Shiga toxin-converting bacteriophages occurring outside bacteria for the evolution and the detection of Shiga toxin-producing Escherichia coli. Front Cell Infect Microbiol. 2014;4:46–48.
   PubMed Web of Science ®Google Scholar
• Rooks DJ, Yan Y, McDonald JE, et al. Development and validation of a qPCR-based method for quantifying Shiga toxin-encoding and other lambdoid bacteriophages. Environ Microbiol. 2010;12(5):1194–1204.
   PubMed Web of Science ®Google Scholar
• Bonanno L, Petit MA, Loukiadis E, et al. Heterogeneity in induction level, infection ability, and morphology of Shiga toxin-encoding phages (Stx phages) from dairy and human Shiga toxin-producing Escherichia coli O26:H11 isolates. Appl Environ Microbiol. 2016;82(7):2177–2186.
   PubMed Web of Science ®Google Scholar
• Kohler B, Karch H, Schmidt H. Antibacterials that are used as growth promoters in animal husbandty can affect the bacteriophages and Shiga toxins 2 from Escherichia coli strains. Microbiology. 2000;146(5):1085–1090.
   PubMedGoogle Scholar
• Zhang X, McDaniel AD, Wolf LE, et al. Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice. J Infect Dis. 2000;181(2):664–670.
   PubMed Web of Science ®Google Scholar
• Feiner R, Argov T, Rabinovich L, et al. A new perspective on lysogeny: prophages as active regulatory switches of bacteria. Nat Rev Microbiol. 2015;13(10):641–650.
   PubMed Web of Science ®Google Scholar
• Iversen H, L’Abée-Lund TM, Aspholm M, et al. Commensal E. coli Stx2 lysogens produce high levels of phages after spontaneous prophage induction. Front Cell Infect Microbiol. 2015;5:5–10.
   PubMed Web of Science ®Google Scholar
• Mitsunaka S, Sudo N, Sekine Y. Lysogenisation of Shiga toxin-encoding bacteriophage represses cell motility. J Gen Appl Microbiol. 2018;64(1):34–41.
   PubMed Web of Science ®Google Scholar
• Bonanno L, Loukiadis E, Mariani-Kurkdjian P, et al. Diversity of Shiga toxin-producing Escherichia coli (STEC) O26:H11 strains examined via stx subtypes and insertion sites of Stx and EspK bacteriophages. Appl Environ Microbiol. 2015;81(11):3712–3721.
   PubMed Web of Science ®Google Scholar
• Jores J, Rumer L, Wieler LH. Impact of the locus of enterocyte effacement pathogenicity island on the evolution of pathogenic Escherichia coli. Int J Med Microbiol. 2004;294(2–3):103–113.
   PubMed Web of Science ®Google Scholar
• Farfan MJ, Torres AG. Molecular mechanisms that mediate colonization of shiga toxin-producing Escherichia coli strains. Infect Immun. 2012;80(3):903–913.
   PubMed Web of Science ®Google Scholar
• Bielaszewska M, Sinha B, Kuczius T, et al. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect Immun. 2005;73(1):552–562.
   PubMed Web of Science ®Google Scholar
• Bielaszewska M, Aldick T, Bauwens A, et al. Hemolysin of enterohemorrhagic Escherichia coli: structure, transport, biological activity and putative role in virulence. Int J Med Microbiol. 2014;304(5–6):521–529.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Shigatoxin/verocytotoxin-producing Escherichia coli (STEC/VTEC) infection. Solna (Sweden): ECDC; 2020. (Annual Epidemiological Report for 2018).
   Google Scholar
• Colello R, Etcheverría AI, Di Conza JA, et al. Antibiotic resistance and integrons in Shiga toxin-producing Escherichia coli (STEC). Braz J Microbiol. 2015;46(1):1–5.
   PubMed Web of Science ®Google Scholar
• Amézquita-López BA, Quiñones B, Soto-Beltrán M, et al. Antimicrobial resistance profiles of Shiga toxin-producing Escherichia coli O157 and Non-O157 recovered from domestic farm animals in rural communities in Northwestern Mexico. Antimicrob Resist Infect Control. 2016;5:1–6.
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci USA. 2015;112(18):5649–5654.
   PubMed Web of Science ®Google Scholar
• Gutiérrez D, Rodríguez-Rubio L, Martínez B, et al. Bacteriophages as weapons against bacterial biofilms in the food industry. Front Microbiol. 2016;7:815–825.
   PubMed Web of Science ®Google Scholar
• Melo LDR, Oliveira H, Santos SB, et al. Phages against infectious diseases. In: Paterson R, Lima N, editors. Bioprospecting. Braga (Portugal): Springer International Publishing; 2017. p. 269–294.
   Google Scholar
• Fernández L, Rodríguez A, García P. Phage or foe: an insight into the impact of viral predation on microbial communities. ISME J. 2018;12(5):1171–1179.
   PubMed Web of Science ®Google Scholar
• Clokie MRJ, Millard AD, Letarov AV, et al. Phages in nature. Bacteriophage. 2011;1(1):31–45.
   PubMedGoogle Scholar
• d’Herelle F. Sur un microbe invisible antagonistedes bacilles dysenteriques. Les Comptes Rendus Del’Académie Des Sci. 1917;165:373–375.
   Google Scholar
• Grose JH, Casjens SR. Understanding the enormous diversity of bacteriophages: the tailed phages that infect the bacterial family Enterobacteriaceae. Virology. 2014;468–470:421–443.
   PubMed Web of Science ®Google Scholar
• Ackermann H. Phage classification and characterization. Methods Mol Bio. 2009;501:127–140.
   PubMedGoogle Scholar
• Barylski J, Enault F, Dutilh BE, et al. Analysis of spounaviruses as a case study for the overdue reclassification of tailed phages. Syst Biol. 2020;69(1):110–123.
   PubMed Web of Science ®Google Scholar
• O’Sullivan L, Bolton D, McAuliffe O, et al. Bacteriophages in food applications: from foe to friend. Annu Rev Food Sci Technol. 2019;10:151–172.
   PubMed Web of Science ®Google Scholar
• Wernicki A, Nowaczek A, Urban-Chmiel R. Bacteriophage therapy to combat bacterial infections in poultry. Virol J. 2017;14:1–13.
   PubMed Web of Science ®Google Scholar
• Węgrzyn G, Kropinski AM, Łoś M, et al. Lysogenic conversion in bacteria of importance to the food industry. In: Sabour PM., Griffiths MW, editors. Bacteriophages control food-and waterborne pathog. Washington (DC): American Society of Microbiology; 2010. p. 157–198.
   Google Scholar
• Erez Z, Steinberger-Levy I, Shamir M, et al. Communication between viruses guides lysis-lysogeny decisions. Nature. 2017;541(7638):488–493.
   PubMed Web of Science ®Google Scholar
• Knowles B, Silveira CB, Bailey BA, et al. Lytic to temperate switching of viral communities. Nature. 2016;531(7595):466–470.
   PubMed Web of Science ®Google Scholar
• Nanda AM, Thormann K, Frunzke J. Impact of spontaneous prophage induction on the fitness of bacterial populations and host-microbe interactions. J Bacteriol. 2015;197(3):410–419.
   PubMed Web of Science ®Google Scholar
• Dydecka A, Bloch S, Rizvi A, et al. Bad phages in good bacteria: role of the mysterious orf63 of λ and Shiga toxin-converting Φ24B bacteriophages. Front Microbiol. 2017;8:1618.
   PubMed Web of Science ®Google Scholar
• Mauro SA, Koudelka GB. Shiga toxin: expression, distribution, and its role in the environment. Toxins. 2011;3(6):608–625.
   PubMed Web of Science ®Google Scholar
• Rehman S, Ali Z, Khan M, et al. The dawn of phage therapy. Rev Med Virol. 2019;29:1–16.
   Web of Science ®Google Scholar
• Połaska M, Sokołowska B. Bacteriophages-a new hope or a huge problem in the food industry. AIMS Microbiol. 2019;5(4):324–347.
   PubMed Web of Science ®Google Scholar
• Tomat D, Migliore L, Aquili V, et al. Phage biocontrol of enteropathogenic and shiga toxin-producing Escherichia coli in meat products. Front Cell Infect Microbiol. 2013;3:10–20.
   PubMed Web of Science ®Google Scholar
• Tomat D, Mercanti D, Balagué C, et al. Phage biocontrol of enteropathogenic and shiga toxin-producing Escherichia coli during milk fermentation. Lett Appl Microbiol. 2013;57(1):3–10.
   PubMed Web of Science ®Google Scholar
• Le TS, Southgate PC, O’Connor W, et al. Bacteriophages as biological control agents of enteric bacteria contaminating edible oysters. Curr Microbiol. 2018;75(5):611–619.
   PubMed Web of Science ®Google Scholar
• Ferguson S, Roberts C, Handy E, et al. Lytic bacteriophages reduce Escherichia coli O157:H7 on fresh cut lettuce introduced through cross-contamination. Bacteriophage. 2013;3(1):e24323.
   PubMedGoogle Scholar
• Liu H, Niu YD, Meng R, et al. Control of Escherichia coli O157 on beef at 37, 22 and 4 °C by T5-, T1-, T4-and O1-like bacteriophages. Food Microbiol. 2015;51:69–73.
   PubMed Web of Science ®Google Scholar
• Carter CD, Parks A, Abuladze T, et al. Bacteriophage cocktail significantly reduces Escherichia coli O157. Bacteriophage. 2012;2(3):178–185.
   PubMedGoogle Scholar
• Sulakvelidze A, Li M, Senecal A, et al. Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7. AEM. 2008;74(20):6230–6238.
   Google Scholar
• Boyacioglu O, Sharma M, Sulakvelidze A, et al. Biocontrol of Escherichia coli O157:H7 on fresh-cut leafy greens. Bacteriophage. 2013;3(1):e24620.
   PubMedGoogle Scholar
• Dalmasso M, Strain R, Neve H, et al. Three new Escherichia coli phages from the human gut show promising potential for phage therapy. PLoS One. 2016;11(6):e0156773.
   PubMed Web of Science ®Google Scholar
• Cui H, Bai M, Yuan L, et al. Sequential effect of phages and cold nitrogen plasma against Escherichia coli O157:H7 biofilms on different vegetables. Int J Food Microbiol. 2018;268:1–9.
   PubMed Web of Science ®Google Scholar
• Sadekuzzaman M, Yang S, Mizan MFR, et al. Reduction of Escherichia coli O157:H7 in biofilms using bacteriophage BPECO 19. J Food Sci. 2017;82(6):1433–1442.
   PubMed Web of Science ®Google Scholar
• Patel J, Sharma M, Millner P, et al. Inactivation of Escherichia coli O157:H7 attached to spinach harvester blade using bacteriophage. Foodborne Pathog Dis. 2011;8(4):541–546.
   PubMed Web of Science ®Google Scholar
• Lee YD, Park JH. Characterization and application of phages isolated from sewage for reduction of Escherichia coli O157:H7 IN biofilm. LWT - Food Sci Technol. 2015;60(1):571–577.
   Web of Science ®Google Scholar
• Tomat D, Quiberoni A, Mercanti D, et al. Hard surfaces decontamination of enteropathogenic and Shiga toxin-producing Escherichia coli using bacteriophages. Food Res Int. 2014;57:123–129.
   Web of Science ®Google Scholar
• Snyder AB, Perry JJ, Yousef AE. Developing and optimizing bacteriophage treatment to control enterohemorrhagic Escherichia coli on fresh produce. Int J Food Microbiol. 2016;236:90–97.
   PubMed Web of Science ®Google Scholar
• Weis M. Impact of the gut microbiome in cardiovascular and autoimmune diseases. Clin Sci. 2018;132(22):2387–2389.
   PubMed Web of Science ®Google Scholar
• Hedin CR, van der Gast CJ, Stagg AJ, et al. The gut microbiota of siblings offers insights into microbial pathogenesis of inflammatory bowel disease. Gut Microbes. 2017;8(4):357–359.
   Web of Science ®Google Scholar
• Guinane CM, Cotter PD. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. 2013;6(4):295–308.
   PubMed Web of Science ®Google Scholar
• Sarker SA, Berger B, Deng Y, et al. Oral application of Escherichia coli bacteriophage: safety tests in healthy and diarrheal children from Bangladesh. Environ Microbiol. 2017;19(1):237–250.
   PubMed Web of Science ®Google Scholar
• Raya RR, Oot RA, Moore-Maley B, et al. Naturally resident and exogenously applied T4-like and T5-like bacteriophages can reduce Escherichia coli O157:H7 levels in sheep guts. Bacteriophage. 2011;1(1):15–24.
   PubMedGoogle Scholar
• Cieplak T, Soffer N, Sulakvelidze A, et al. A bacteriophage cocktail targeting Escherichia coli reduces E. coli in simulated gut conditions, while preserving a non-targeted representative commensal normal microbiota. Gut Microbes. 2018;9(5):391–399.
   PubMed Web of Science ®Google Scholar
• De Sordi L, Khanna V, Debarbieux L. The gut microbiota facilitates drifts in the genetic diversity and infectivity of bacterial viruses. Cell Host Microbe. 2017;22(6):801.e3–808.e3.
   Web of Science ®Google Scholar
• Cookson AL, Woodward MJ. The role of intimin in the adherence of enterohaemorrhagic Escherichia coli (EHEC) O157:H7 to HEp-2 tissue culture cells and to bovine gut explant tissues. Int J Med Microbiol. 2003;292(7–8):547–553.
   PubMed Web of Science ®Google Scholar
• Górski A, Międzybrodzki R, Łobocka M, et al. Phage therapy: what have we learned? Viruses. 2018;10(6):228–288.
   Web of Science ®Google Scholar
• Brüssow H. Hurdles for phage therapy to become a reality—an editorial comment. Viruses. 2019;11(6):557.
   Web of Science ®Google Scholar
• Bureau of Chemical Safety of Canada, Food Directorate, Health Products and Food Branch. Antimicrobial food processing aid uses on red meat and poultry meat for which Health Canada has expressed no objection. 2019.
   Google Scholar
• Office of Parliamentary Counsel. Food Standards Australia New Zealand Act 1991, Compilation nº 28 2018.
   Google Scholar
• Andreoletti O, Baggesen DL, Bolton D, et al. Scientific opinion on the evaluation of the safety and efficacy of Listex TM P100 for the removal of listeria monocytogenes surface contamination of raw fish. EFSA J. 2012;10:2615.
   Google Scholar
• Panel E, Hazards B. Evaluation of the safety and efficacy of ListexTM P100 for reduction of pathogens on different ready‐to‐eat (RTE) food products. EFSA J. 2016;14(8):e04565.
   Web of Science ®Google Scholar
• General Secretariat of the Council. Comments on the council’s rules of procedure European council’s and council’s rules of procedure. Luxembourg (Luxembourg): Publications Office of the European Union; 2016.
   Google Scholar
• The Council of the European Union. Council Decision 1999/468/EC laying down the procedures for the exercise of implementing powers (28 June 1999) — Consolidated version 2006. Off J Eur Communities. 1999;2:1998–2001.
   Google Scholar
• Andreoletti O, Budka H, Buncic S, et al. The use and mode of action of bacteriophages in food production. Eur Food Saf Auth. 2009;1076:1–26.
   Google Scholar
• Andreoletti O, Baggesen DL, Bolton D, et al. Scientific opinion on the maintenance of the list of QPS biological agents intentionally added to food and feed (2013 update). EFSA J. 2013;11(11):3449.
   Google Scholar
• Fauconnier A. Phage therapy regulation: from night to dawn. Viruses. 2019;11(4):352.
   PubMed Web of Science ®Google Scholar
• Sundh I, Bolton D, Vlak J, et al. Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 8: suitability of taxonomic units notified to EFSA until March 2018. EFSA J. 2018;16(7):e05315.
   PubMed Web of Science ®Google Scholar
• Lee H, Ku HJ, Lee DH, et al. Characterization and genomic study of the novel bacteriophage HY01 infecting both Escherichia coli O157:H7 and Shigella flexneri: potential as a biocontrol agent in food. PLoS One. 2016;11(12):e0168985.
   PubMed Web of Science ®Google Scholar
• Moye Z, Woolston J, Sulakvelidze A. Bacteriophage applications for food production and processing. Viruses. 2018;10(4):205.
   PubMed Web of Science ®Google Scholar
• Imamovic L, Ballesté E, Martínez-Castillo A, et al. Heterogeneity in phage induction enables the survival of the lysogenic population. Environ Microbiol. 2016;18(3):957–969.
   PubMed Web of Science ®Google Scholar
• Bonanno L, Delubac B, Michel V, et al. Influence of stress factors related to cheese-making process and to STEC detection procedure on the induction of Stx phages from STEC O26:H11. Front Microbiol. 2017;8:296–297.
   PubMed Web of Science ®Google Scholar
• Fang Y, Mercer RG, McMullen LM, et al. Induction of Shiga toxinencoding prophage by abiotic environmental stress in food. Appl Environ Microbiol. 2017;83:1–13.
   Web of Science ®Google Scholar
• Matsushiro A, Sato K, Miyamoto H, et al. Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol. 1999;181(7):2257–2260.
   PubMed Web of Science ®Google Scholar
• Liao Y, Quintela IA, Nguyen K, et al. Investigation of prevalence of free Shiga toxin- producing Escherichia coli (STEC) -specific bacteriophages and its correlation with STEC bacterial hosts in a produce-growing area in Saline, California.. Plos One. 2018;13:1–12.
   Web of Science ®Google Scholar
• García-Aljaro C, Muniesa M, Blanco JE, et al. Characterization of Shiga toxin-producing Escherichia coli isolated from aquatic environments. FEMS Microbiol Lett. 2005;246(1):55–65.
   PubMed Web of Science ®Google Scholar
• DebRoy C, Fratamico PM, Yan X, et al. Comparison of O-antigen gene clusters of all O-serogroups of Escherichia coli and proposal for adopting a new nomenclature for O-typing. PLoS One. 2016;11:1–13.
   Web of Science ®Google Scholar
• Looft T, Allen HK, Cantarel BL, et al. Bacteria, phages and pigs: the effects of in-feed antibiotics on the microbiome at different gut locations. ISME J. 2014;8(8):1566–1576.
   PubMed Web of Science ®Google Scholar
• Jovel J, Patterson J, Wang W, et al. Characterization of the gut microbiome using 16S or shotgun metagenomics. Front Microbiol. 2016;7:1–17.
   PubMed Web of Science ®Google Scholar
• Chu DM, Antony KM, Ma J, et al. The early infant gut microbiome varies in association with a maternal high-fat diet. Genome Med. 2016;8(1):77.
   PubMed Web of Science ®Google Scholar
• Seekatz AM, Aas J, Gessert CE, et al. Recovery of the gut microbiome following fecal microbiota transplantation. MBio. 2014;5(3):e00893.
   PubMed Web of Science ®Google Scholar
• Gasparrini AJ, Crofts TS, Gibson MK, et al. Antibiotic perturbation of the preterm infant gut microbiome and resistome. Gut Microbes. 2016;7(5):443–449.
   PubMed Web of Science ®Google Scholar
• Doss J, Culbertson K, Hahn D, et al. A review of phage therapy against bacterial pathogens of aquatic and terrestrial organisms. Viruses. 2017;9(3):50.
   PubMed Web of Science ®Google Scholar
• Endersen L, O’Mahony J, Hill C, et al. Phage therapy in the food industry. Annu Rev Food Sci Technol. 2014;5:327–349.
   PubMed Web of Science ®Google Scholar
• Sabouri S, Sepehrizadeh Z, Amirpour-Rostami S, et al. A minireview on the in vitro and in vivo experiments with anti-Escherichia coli O157:H7 phages as potential biocontrol and phage therapy agents. Int J Food Microbiol. 2017;243:52–57.
   PubMed Web of Science ®Google Scholar
• Bruttin A, Brüssow H. Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother. 2005;49(7):2874–2878.
   PubMed Web of Science ®Google Scholar
• Dudek-Wicher RK, Junka A, Bartoszewicz M. The influence of antibiotics and dietary components on gut microbiota. Prz Gastroenterol. 2018;13(2):85–92.
   PubMed Web of Science ®Google Scholar
• Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: a randomized trial in children from Bangladesh. EBioMedicine. 2016;4:124–137.
   PubMed Web of Science ®Google Scholar
• Gindin M, Febvre HP, Rao S, et al. Bacteriophage for Gastrointestinal Health (PHAGE) Study: evaluating the safety and tolerability of supplemental bacteriophage consumption. J Am Coll Nutr. 2018:38(1):68–75.
   PubMed Web of Science ®Google Scholar
• Maura D, Debarbieux L. On the interactions between virulent bacteriophages and bacteria in the gut. Bacteriophage. 2012;2(4):e23557.
   PubMedGoogle Scholar
• Maura D, Morello E, Du Merle L, et al. Intestinal colonization by enteroaggregative Escherichia coli supports long-term bacteriophage replication in mice. Environ Microbiol. 2012;14(8):1844–1854.
   PubMed Web of Science ®Google Scholar
• Sarhan W. a, Azzazy HME. Phage approved in food, why not as a therapeutic? Expert Rev anti Infect Ther. 2015;13(1):91–101.
   PubMed Web of Science ®Google Scholar